SCHEMBL9145459

SCHEMBL9145459

O=C1CCCCC1Cc1ccc(-c2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.54
PTGS1 P23219 4/20 0.54
KMT2A Q03164 2/20 0.54
OPRK1 P41145 1/20 0.54
HTT P42858 1/20 0.54
CYP26A1 O43174 1/20 0.50
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
DDB1 Q16531 1/20 0.44
CRBN Q96SW2 1/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA4 P22748 2/20 0.44
CA6 P23280 2/20 0.44
HSD11B1 P28845 1/20 0.43
MCL1 Q07820 1/20 0.42
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9144882 0.97 PTGS2 (0.57) PTGS2PTGS1KMT2AOPRK1HTT
SCHEMBL9790769 0.91 PTGS2 (0.57) PTGS2PTGS1KMT2AOPRK1HTT
SCHEMBL4595 0.91 PTGS2 (0.57) PTGS2PTGS1KMT2AOPRK1HTT
SCHEMBL29169546 0.91 PTGS2 (0.57) PTGS2PTGS1KMT2AOPRK1HTT
SCHEMBL225031 0.90 PTGS2 (0.56) PTGS2PTGS1KMT2AOPRK1HTT
SCHEMBL7338783 0.90 PTGS2 (0.56) PTGS2PTGS1KMT2AOPRK1HTT
SCHEMBL23056654 0.86 PTGS2 (0.59) PTGS2PTGS1KMT2AOPRK1HTT
SCHEMBL793526 0.86 PTGS2 (0.59) PTGS2PTGS1KMT2AOPRK1HTT
SCHEMBL29169544 0.86 PTGS2 (0.59) PTGS2PTGS1KMT2AOPRK1HTT
SCHEMBL31285560 0.80 KDM4E (0.47) PTGS2PTGS1KMT2AOPRK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5387693-A Intermediates for inhibitors of cholesterol biosynthesis ORTHO PHARMACEUTICAL CORPORATION (US) 1995-02-07 US disclosed
US-5315012-A Prevention of hypercholesterolemia, hyperlipoproteinemia and atherosclerosis ORTHO PHARMACEUTICAL CORPORATION (US) 1994-05-24 US disclosed
US-5250561-A Anticholesterool agents; prevention of hyperlipoproteinemia and atherosclerosis ORTHO PHARMACEUTICAL CORPORATION (US) 1993-10-05 US disclosed
EP-0529854-A2 Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-COA reductase inhibitors ORTHO PHARMACEUTICAL CORPORATION (US) 1993-03-03 EP disclosed
US-5134155-A Anticholesterol ORTHO PHARMACEUTICAL CORPORATION (US) 1992-07-28 US disclosed